Lesson series
IVD Spotlight
In a fast-moving IVD regulatory environment, staying up to date is essential. This focused clinical spotlight course is designed for experienced MedTech professionals working in Clinical Affairs, performance evaluation, and post-market performance follow-up. It examines the latest topics and emerging discussions under the IVDR, incorporating expert insights and opinions from leading industry professionals.
Drawing on insights from leading conferences and industry forums, this course explores evolving approaches to performance evaluation, post-market performance follow-up (PMPF), real-world performance data, and scientific validity requirements. The program supports ongoing professional development by helping participants stay aligned with current thinking, key challenges, and practical strategies.
Format
Online
Starting date
October 2026
Available for
6 months
Duration
6 sessions
Why you should join this course?
You will learn to:
- TBD
What can you expect?
Self-funded*
Early Bird
250€
Normal Price: 300€
Corporate
Early Bird
500€
Normal Price: 750€
Student**
200€
Keep yourself informed
Sign up for your newsletter and we will let you know once the Early Bird offer for this course is available!
Thank you!
Meet the Speakers
Michael D'Agosto
MODERATOR
Michael D’Agosto is Professor and Dean of Studies M.Sc. Medical Devices - Regulatory Affairs at Hochschule Furtwangen University. He is a medical doctor (MD) and medical engineer by training and worked in the medical device industry prior to his academic career. Michael is also Scientific Expert and Partner at Escentia GmbH. Michael has been part of Edvance MedTech from the very beginning, sharing his expertise and experience. He is essential for our progression with his ability to explain complex issues in a comprehensible way and for his openness to support everyone.
Cécile van der Heijden
MODERATOR
Cécile van der Heijden is an attorney-at-law at Axon Lawyers and strategist in European life sciences regulation, with expertise spanning MedTech, AI, data, biotech and health law. Her special interest lies with cross-legislation and FemTech. Recognised for her cross-legislation expertise, she brings coherence to complex regulatory frameworks. She is a frequent speaker at international conferences and has published on medical devices, data governance, and health law, as well as on history, combining professional practice with academic inquiry.
Elisabeth Oltmanns
MODERATOR
Elisabeth Oltmanns is a PhD student and her research focuses on the integration of clinical and non-clinical data (eclipse-md.com). With a background in Biomedical Engineering and an MSc in Regulatory Affairs, she combines technical expertise with regulatory insight. Alongside her academic work, she consults through Escentia, a boutique clinical affairs consultancy supporting medium-risk medical devices. Passionate about advancing medical device development, she is dedicated to transforming clinical evaluations from a regulatory requirement into a strategic advantage.
Laura Irwin Rossing
Regulatory Affairs specialist
Laura Irwin Rossing is a Regulatory Affairs specialist focused on EU medical device compliance, with hands-on experience supporting small and emerging enterprises. She works closely with startups and SMEs to navigate the EU MDR, helping them build practical, scalable regulatory strategies. Her approach emphasizes in providing a pragmatic level of documentation, efficient processes, and realistic pathways to CE marking.
Nina Dusper
Director of Quality & Regulatory Affairs
Nina Dusper is a senior Quality and Regulatory Affairs leader with more than a decade of experience in global medical device compliance, regulatory strategy and international submissions, and quality system transformation. As Director of Quality & Regulatory Affairs at RetInSight GmbH, she defines and leads the company’s quality and regulatory framework for pioneering AI-supported medical devices in ophthalmology. Her expertise spans FDA regulations, EU MDR, global market registrations, UDI implementation, and audit readiness.
Yu Jin
MDR CLINICAL EXPERT
Yu Jin is a clinical and regulatory affairs specialist with an MD and PhD in cardiology and cardiovascular epidemiology. With over 15 years of experience across clinical practice, research, the medical device industry, and regulatory sectors, Dr. Jin has developed a comprehensive understanding of both the clinical and scientific aspects of medical device development and evaluation. Currently a consultant, her career has included leadership roles in clinical and regulatory strategy, particularly in the areas of EU MDR clinical evaluations and clinical investigations. Dr. Jin has extensive expertise in the Notified Body conformity assessment process, including Clinical Evaluation Reports (CER), Post-Market Clinical Follow-up (PMCF) studies, and clinical investigations.An author of over 50 peer-reviewed scientific publications, Dr. Jin is also recognised for her deep clinical expertise in cardiovascular devices.
And more...
Our students say
Excellent speakers, interesting discussions, fun and great atmosphere.
andrea
Your initiative is inspiring, with a great delivery and perfect timing. The team is welcoming and shows a very serious intent to find and propose ways of sailing through the realities imposed by
the MDR and its implementation...
Bruno Oliviera, cmo
It is a very interesting and informative course, excellent trainers/speakers.
peter
Offer for Teams
Send more people from your team and get up to 40 % discount!
25% of team (min. 2) —> 10% discount
50% of team (min. 3) —> 20% discount
75% of team (min. 4) —> 30% discount
Full team (min 5) —> 40% discount
Self-funded*
???
Corporate
???
Student**
???
